Cti Biopharma Corp
CTICDelisted Jun 26, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000891293
Cti Biopharma Corp was delisted on Jun 26, 2023; its insiders filed their last Form 4 on Jun 28, 2023; 133 institutions reported holding it in 13F filings for Q1 2023, worth $475.2M in total; no superinvestor held it.
Q4 2021 vs. Q3 2021
How the institutions holding Cti Biopharma Corp changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Of which not filed for Q4 2021 | Q4 2021 | Change |
|---|---|---|---|---|
| Holders | 56 | 1 | 63 | +8 |
| Shares | 54.1M | 60.0K | 47.7M | −6.34M (−11.7%) |
| Value | $159.6M | $177.0K | $118.3M | −$41.1M (−25.8%) |
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (19)
Institutions that held Cti Biopharma Corp at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Silverarc Capital Management, LLC | 1,483,829 | $3.68M | 1.65% |
| Lion Point Capital, LP | 1,223,595 | $3.03M | 1.00% |
| Bleichroeder LP | 250,000 | $620.0K | 0.10% |
| Knott David M Jr | 221,079 | $548.0K | 0.21% |
| Atom Investors LP | 114,110 | $283.0K | 0.08% |
| Lakeside Advisors, INC. | 97,780 | $242.0K | 0.18% |
| Marshall Wace, LLP | 89,090 | $221.0K | 0.00% |
| Simplex Trading, LLC | 82,126 | $203.0K | 0.01% |
| Goldman Sachs Group Inc | 61,047 | $152.0K | 0.00% |
| LPL Financial LLC | 47,224 | $117.0K | 0.00% |
| Bartlett & Co. LLC | 36,500 | $91.0K | 0.00% |
| Bartlett & Co. Wealth Management LLC | 36,500 | $90.5K | 0.00% |
| Gilbert & Cook, Inc. | 29,190 | $72.0K | 0.01% |
| The PNC Financial Services Group, Inc. | 10,000 | $25.0K | 0.00% |
| TD Waterhouse Canada Inc. | 45 | $109 | 0.00% |
| National Bank of Canada | 5 | $0 | 0.00% |
| JJJ Advisors Inc. | 190 | $0 | 0.00% |
| Sound Income Strategies, LLC | 20 | $0 | 0.00% |
| Concord Wealth Partners | 3 | $0 | 0.00% |
Sold out (11)
Institutions that held Cti Biopharma Corp at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| OrbiMed Advisors LLC | 7,520,600 | $22.2M |
| Sofinnova Investments, Inc. | 2,074,714 | $6.12M |
| Gyon Technologies Capital Management, LP | 135,003 | $398.0K |
| EPIQ Capital Group, LLC | 120,939 | $357.0K |
| Raymond James Financial Services Advisors, Inc. | 72,871 | $215.0K |
| Capstone Investment Advisors, LLC | 50,445 | $149.0K |
| Cubist Systematic Strategies, LLC | 18,203 | $54.0K |
| KBC Group NV | 14,325 | $42.0K |
| Fieldpoint Private Securities, LLC | 1,000 | $3.00K |
| O'Shaughnessy Asset Management, LLC | 321 | $1.00K |
| Harbour Investments, Inc. | 9 | $0 |
Not filed for Q4 2021 yet (1)
Institutions that held Cti Biopharma Corp at the end of Q3 2021 and haven't filed a 13F for Q4 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Knott David M | 60,000 | $177.0K |